Faes Farma SA

€4.545+€0.01 (0.22%)

Estimate

P/E

16.8

EPS

0.27

Beta

0.341

Growth

Revenue, YoY

148%

Net income, YoY

137.45%

FCF, YoY

-2.12%

Forecast

P/E (FWD)

12.9

EPS (FWD)

0.352

Dividends

Dividend yield

3.1%

Annual payout

€0.14

Next ex. div date

January 2, 27

Payout

40.91%

Div.growth, 5y

-1.49%

Div.rating

About the company

Ticker

FAE

ISIN

ES0134950F36

Country

Spain

Sector (GICS)

Healthcare

Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Animal Nutrition and Health; and Pharmaceutical Raw Materials segments. It engages in chemical and pharmaceutical products, foodstuffs, cosmetics, dietetics and medicinal plants services, as well as acquiring, purchasing, disposing of, investing in, holding, using, managing, administering, marketing and leasing corporations, securities and real estate, patents, trademarks and registered brands and equity interests. The company also provides animal nutrition and health products. It offers products for various therapeutic areas. Faes Farma, S.A. was incorporated in 1933 and is headquartered in Leioa, Spain.

Frequently asked questions

What sector does Faes Farma SA (FAE) operate in?

Faes Farma SA belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Faes Farma SA (FAE) current stock price?

As of the latest data, Faes Farma SA stock price is €4.55, with a previous close of €4.54. Faes Farma SA gained €0.01 in the last trading session, representing a 0.22% increase.

What is Faes Farma SA (FAE) current market capitalization?

Faes Farma SA market cap is approximately 1.42 billion.

What is Faes Farma SA (FAE) Earnings Per Share (EPS)?

The trailing EPS is €0.27, and the forward EPS is €0.35.

What is Faes Farma SA (FAE) Price-to-Earnings (P/E) ratio?

Faes Farma SA current P/E ratio is 16.83, with a forward P/E of 12.89.

What is Faes Farma SA (FAE) EBITDA?

Faes Farma SA EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 90.83 million.

Does Faes Farma SA (FAE) pay dividends?

Yes. Faes Farma SA pays semiannual dividends with an annualized yield of 3.1% and an estimated annual payout of €0.14 per share.

When is the next ex-dividend date for Faes Farma SA (FAE)?

The next ex-dividend date is scheduled for January 02, 2027.

When is Faes Farma SA (FAE) next earnings report?

Faes Farma SA is expected to release its next earnings report on June 30, 2026.

What is Faes Farma SA (FAE) beta (volatility) score?

Faes Farma SA has a beta of 0.341, indicating lower volatility than the overall market.